Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 13

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 13
---
EquityPreferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024, respectively)— — Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,831,291 and 43,630,211 issued and 36,047,141 and 36,350,425 outstanding at 2025 and 2024, respectively)0.4 0.4 Additional paid-in capital191.2 176.8 Retained earnings489.5 572.0 Accumulated other comprehensive income (loss)(2.4)(41.4)Treasury stock, common stock, at cost (7,784,150 shares - 2025 and 7,279,786 shares - 2024)(540.6)(512.6)Total Equity138.1 195.2 Total Liabilities and Equity$1,833.8 $2,022.6 

The accompanying notes are an integral part of these financial statements.

5

INGEVITY CORPORATION

Condensed Consolidated Statements of Cash Flows (Unaudited)Nine Months Ended September 30,In millions2025 (1)2024 (1)Cash provided by (used in) operating activities:Net income (loss)$(82.5)$(446.9)Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:Depreciation and amortization78.5 83.1 Non cash operating lease costs11.5 14.7 Deferred income taxes20.9 (111.0)Disposal/impairment of assets1.8 1.0 Restructuring and other (income) charges, net44.1 162.8 CTO resales— 50.8 LIFO charge (liquidation)(8.5)(1.2)Share-based compensation13.8 9.8 (Gain) loss on strategic investment2.5 11.4 Goodwill impairment charge183.8 349.1 CTO supply contract termination charges— 100.0 Other non-cash items7.5 9.4 Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:Accounts receivable, net(33.9)(7.0)In